Sonata Therapeutics
PrivateLast Round
Corporate Funding
May 18, 2022
Company Overview
Sonata Therapeutics operates in Healthcare & Life Sciences and is based in Watertown, Massachusetts. Its latest recorded funding round was a Corporate Funding round in May 2022.
Sonata Therapeutics is a biotechnology company that develops small molecule drugs and genetic therapeutics to reprogram the cellular microenvironment for the treatment of oncology, fibrosis, and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sonata Therapeutics Comparables
Compare Sonata Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novasenta | 84% | |
| Incendia Therapeutics | 81% | |
| Apmonia Therapeutics | 75% |
For institutional investors. Book with your work email.
Sonata Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 18, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sonata Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Monthly visitors increased 165% MoM.
- Jan 8, 2026
Monthly visitors increased 162% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
Sonata Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sonata Therapeutics's valuation, stock price, and market status.
Is Sonata Therapeutics a public or private company?
Sonata Therapeutics is a private company.
What is the current stock price of Sonata Therapeutics?
Sonata Therapeutics is a private company, so its shares have no public market price. Caplight tracks Sonata Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sonata Therapeutics worth (valuation)?
Valuation information for Sonata Therapeutics is not publicly available.
Can I buy Sonata Therapeutics stock?
Sonata Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sonata Therapeutics's last funding round?
Sonata Therapeutics's most recent funding round was Corporate Funding on May 18, 2022.
Who are the main investors in Sonata Therapeutics?
Key investors in Sonata Therapeutics include Flagship Pioneering.
Will Sonata Therapeutics IPO soon?
No public IPO plans have been announced for Sonata Therapeutics.
How can I track Sonata Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Sonata Therapeutics's shares on secondary markets.